Patent Grant
12076522
The present disclosure generally relates to a device for disinfecting and sterilizing access ports with, e.g., male and female luer fitting, and, in particular, to disinfecting and sterilizing devices capable of accommodating multiple types of connectors.
Vascular access devices (VAD's) are commonly used therapeutic devices and include intravenous (IV) catheters. There are two general classifications of VAD's, peripheral catheters and central venous catheters. Bacteria and other microorganisms may gain entry into a patient's vascular system from access hubs and ports/valves upon connection to the VAD to deliver the fluid or pharmaceutical. Each access hub (or port/valve or connection) is associated with some risk of transmitting a catheter related bloodstream infection (CRBSI), which can be costly and potentially lethal.
In order to decrease catheter-related bloodstream infection (CRBSI) cases and to ensure VAD's are used and maintained correctly, standards of practice have been developed, which include disinfecting and cleaning procedures.
Disinfection caps have been added to the Society for Healthcare Epidemiology of America (SHEA) guidelines and early indications are that caps will also be incorporated into the 2016 Infusion Nurses Standards (INS) guidelines.
In developed markets, when utilizing an IV catheter, a needleless connector will typically be used to close off the system and then subsequently accessed to administer medication or other necessary fluids via the catheter to the patient. INS Standards of Practice recommend the use of a needleless connector and state that it should be “consistently and thoroughly disinfected using alcohol, tincture of iodine or chlorhexidine gluconate/alcohol combination prior to each access.” The disinfection of the needleless connector is ultimately intended to aid in the reduction of bacteria that could be living on the surface and possibly lead to a variety of catheter related complications including the CRBSI events described before. Nurses will typically utilize a 70% IPA alcohol pad to complete this disinfection task by doing what is known as “scrubbing the hub.” However, compliance to this practice is typically very low. In addition to a lack of compliance to “scrubbing the hub”, it has also been noted through clinician interviews that there is often a variation in scrub time, dry time and the number of times the needleless connector is scrubbed.
Throughout the sequence of procedures associated with the transmission of a microorganism that can cause a CRBSI, there are many risks of contact or contamination. Contamination can occur during drug mixing, attachment of a cannula, and insertion into the access hub. Because the procedure to connect to a VAD is so common and simple, the risk associated with entry into a patient's vascular system has often been overlooked. Presently, the risk to hospitals and patients is a substantial function of the diligence of the clinician performing the connection, and this diligence is largely uncontrollable.
Currently, caps for male needleless connectors, female needleless connectors, intravenous (IV), and hemodialysis lines use different designs and are therefore limited to the types of connectors to which the cap can be attached. Prior disinfecting caps were designed to fit one type of connector only, and were specific to one particular size and/or shape of connector. Thus, there is a need for a disinfecting device capable of accommodating multiple types of connectors to streamline the disinfecting process. There is also a need for a disinfecting device capable of continuous disinfection for multiple days.
One aspect of the present disclosure pertains to a device for connection to a medical connector. The device, according to a first exemplary embodiment of the present disclosure, generally comprises an outer cap, an inner cap, and a peelable seal. In one or more embodiments, the outer cap comprises an integral body, a closed end, and an annular wall having a length extending from the closed end to an open end defining a chamber. The chamber may contain an absorbent material and disinfectant or antimicrobial agent. The open end of the outer cap defines an end face. The annular wall of the outer cap includes an outer cap exterior wall surface and an outer cap interior wall surface. The interior wall surface includes one or more threads. The inner cap includes an integral body having an annular wall having an exterior wall surface and an interior wall surface with a first end of the inner cap facing the closed end of the outer cap, a second end of the inner cap facing the open end of the outer cap. The exterior wall surface of the first end of the inner cap includes one or more threads which may engage with the threads on the interior wall surface of the outer cap. The exterior wall surface of the second end of the inner cap includes one or more threads adapted to engage a male luer connector. When the threads of the inner cap are engaged with a male luer connector, the threads of the outer cap will be passive. Alternatively, when the threads of the outer cap are engaged with a female luer connector, the threads of the inner cap will be passive. In one or embodiments, the peelable seal may be placed on the end face to prevent the disinfectant or the antimicrobial agent from exiting the chamber.
When the device is removed from its packaging, the open end of the outer cap is situated on a same horizontal plane as the second end of the inner cap in an initial state. To connect the device to a male luer connector, the user applies an axial load such that a male luer connector is engaged to the one or more threads of the exterior wall surface of the second end of the inner cap and rotated in a clockwise direction, the inner cap partially protrude out from the open end of the outer cap. When the inner cap partially protrudes out from the open end of the outer cap, there is no space that exists between the device and the connector. When a male luer connector is engaged to the one or more threads of the exterior wall surface of the second end of the inner cap and rotated in a counter-clockwise direction, the inner cap retracts into the chamber of the outer cap. When a female luer connector is engaged to the device, the inner cap slips and retracts into the chamber of the outer cap. Once the device is engaged to the connector, the device may be removed from the connector by rotating the device counter-clockwise. Upon disengagement, the inner cap and the outer cap remain intact and attached to each other.
The device is designed to be compatible in interacting with various disinfectants. In one or more embodiments, the disinfectant or antimicrobial agent may include variations of alcohol or chlorhexidine. The disinfectant or antimicrobial agent can be a fluid or a gel selected from the group consisting essentially of isopropyl alcohol, ethanol, 2-propanol, butanol, methylparaben, ethylparaben, propylparaben, propyl gallate, butylated hydroxyanisole (BHA), butylated hydroxytoluene, t-butyl-hydroquinone, chloroxylenol, chlorohexidine, chlorhexidine diacetate, chlorohexidine gluconate, povidone iodine, alcohol, dichlorobenzyl alcohol, dehydroacetic acid, hexetidine, triclosan, hydrogen peroxide, colloidal silver, benzethonium chloride, benzalkonium chloride, octenidine, antibiotic, and mixtures thereof.
In one or more embodiments, the outer cap exterior wall surface includes a plurality of grip members.
In one or more embodiments, the female connector may be a needle-free connector, stopcock, or hemodialysis connector. In one or more embodiments, the male connector may be an intravenous tubing end or stopcock.
Another aspect of the present disclosure pertains to a device for connection to a medical connector according to a second exemplary embodiment of the present disclosure generally comprises an outer cap, an inner cap, and a peelable seal.
The outer cap comprises a body, a closed end, an annular wall having a length extending from the closed end to an open end and defining a chamber containing an absorbent material and disinfectant or antimicrobial agent. The open end defines an end face. Annular wall of the outer cap includes an outer cap exterior wall surface and an outer cap interior wall surface. The outer cap interior wall surface comprises one or more grooves and one or more threads adapted to engage with a female luer connector. In one or more embodiments, the female connectors may be in the form of needle-free connectors, stopcocks, and hemodialysis connectors. In one or more alternate embodiments, the body of the outer cap may be comprised of two components, where a rear-end component with an inner cavity is screwed onto the front-end component of the cap body via threads or welding.
The inner cap comprises a body having an annular wall having an exterior wall surface and an interior wall surface with a first end of the inner cap facing the closed end of the outer cap. A second end of the inner cap faces the open end of the outer cap. The outer cap interior wall surface comprises one or more grooves along which the inner cap is able to slide. The exterior wall surface of the first end of the inner cap includes two shaft-like wings to fit into the one or more grooves of the outer cap interior wall surface to facilitate the slide motion without allowing signification relative rotation between the inner cap with respect to the outer cap. The outer-most diameter of the threads of the inner cap is designed to have minimum interference, e.g. sliding fit or strip fit, with the threads of the outer cap to allow relative linear motion and also facilitate assembly of device. The teeth depth of the threads of the inner cap and the outer cap is desired to be sufficient to engage with the male and female luer connectors. The exterior wall surface of the second end of the inner cap includes one or more thread-tabs adapted to engage a male luer connector. In one or more embodiments, the exterior wall surface of the second end of the inner cap includes two thread-tabs adapted to engage a male luer connector. The male luer connectors include collars with female threads. In one or more embodiments, the male connector can be an intravenous (I.V.) tubing end, stopcock or male lock luer.
Inner cap can slide back and forth with respect to outer cap. In one or more embodiments, the open end of the outer cap is situated on a same horizontal plane as the second end of the inner cap in an initial state. When a male luer connector is engaged to the one or more threads of the exterior wall surface of the second end of the inner cap, the inner cap slides against the outer cap to partially protrude out from the open end of the outer cap. When a female luer connector is engaged to the device, the inner cap slides against the outer cap and retracts into the chamber of the outer cap to allow the female luer connector to engage the one or more threads on the interior wall surface of the outer cap.
Disinfecting caps currently on the market are capable of only disinfecting one of the three types of luer fitting, namely female luer of needle-free connectors, female luer of stopcocks, and male luer connectors on intravenous injection sites. Thus, to avoid having to use different types of disinfecting caps to clean different types of connectors, the device is self-adaptive to different types of luer connectors due to the sliding mechanism between the inner cap that engages with male luer connectors and the outer cap that engages with female luer connectors, thereby allowing the user to clean different types of connectors with a single device. Upon mounting the outer cap onto female luer connectors, the inner cap retreats towards the chamber at the closed end of the outer cap, thus, providing space for female luer connectors to be inserted and screwed onto the threads of the outer cap. Upon mounting the inner cap of device onto a male luer connector, the one or more thread-tabs on the exterior wall surface of the second end of the inner cap engage with the threads on the male luer connector. Hence, the disclosed cap can be mounted onto both male and female luers.
The device can achieve disinfection when used on luer connectors by integrating disinfectant or antimicrobial agent in the chamber of the outer cap. The disinfectant or antimicrobial agent can be directly included in the chamber or disinfectant or antimicrobial agent can be absorbed into sponges or foam material that fills the chamber of outer cap. In one or more embodiments, the disinfectant or antimicrobial agent is selected from the group consisting essentially of isopropyl alcohol, ethanol, 2-propanol, butanol, methylparaben, ethylparaben, propylparaben, propyl gallate, butylated hydroxyanisole (BHA), butylated hydroxytoluene, t-butyl-hydroquinone, chloroxylenol, chlorohexidine, chlorhexidine diacetate, chlorohexidine gluconate, povidone iodine, alcohol, dichlorobenzyl alcohol, dehydroacetic acid, hexetidine, triclosan, hydrogen peroxide, colloidal silver, benzethonium chloride, benzalkonium chloride, octenidine, antibiotic, and mixtures thereof.
The peelable seal on the end face is to prevent the disinfectant or the antimicrobial agent from exiting the chamber.
In one or more embodiments, the outer cap exterior wall surface includes a plurality of grip members.
The outer-most diameter of the one or more thread-tabs of the inner cap has a minimum interference with the threads of the outer cap to allow for relative linear motion.
Another aspect of the present disclosure pertains to a device for connection to a medical connector according to a third exemplary embodiment of the present disclosure generally comprises an outer cap, an inner cap, and a peelable seal.
The outer cap comprises an integral body, a closed end, an annular wall having a length extending from the closed end to an open end and defining a chamber containing an absorbent material and disinfectant or antimicrobial agent. The open end defines an end face.
The annular wall of the outer cap comprises an outer cap exterior wall surface and an outer cap interior wall surface. The outer cap interior wall surface includes one or more grooves and one or more threads adapted to engage with a female luer connector, wherein at least a portion of said one or more threads on the outer cap interior wall surface comprise a gap that does not engage a mating feature of the inner cap.
The inner cap slidably engages with the outer cap. The inner cap comprises an integral body having an annular wall having an exterior wall surface and an interior wall surface with a first end of the inner cap facing the closed end of the outer cap and a second end of the inner cap facing the open end of the outer cap. The exterior wall surface of the first end of the inner cap includes two shaft-like wings to fit into the one or more grooves of the outer cap interior wall surface and facilitate the slide motion without allowing signification relative rotation between the inner cap with respect to the outer cap. The exterior wall surface of the second end of the inner cap includes one or more thread-tabs adapted to engage a male luer connector. The inner cap is in a slidable arrangement with the outer cap.
The peelable seal on the end face to prevent the disinfectant or the antimicrobial agent from exiting the chamber.
In one or more embodiments, the open end of the outer cap is situated on a same horizontal plane as the second end of the inner cap in an initial state.
When a male luer connector is engaged to the one or more threads of the exterior wall surface of the second end of the inner cap and rotated in a clockwise direction, the inner cap partially protrudes out from the open end of the outer cap.
When a male luer connector is engaged to the one or more threads of the exterior wall surface of the second end of the inner cap and rotated in a counter-clockwise direction, the inner cap retracts into the chamber of the outer cap.
When a female luer connector is engaged to the device, the inner cap slides against the outer cap and retracts into the chamber of the outer cap to allow the female luer connector to engage the one or more threads on the interior wall surface of the outer cap.
In one or more embodiments, the exterior wall surface of the second end of the inner cap includes two thread-tabs adapted to engage a male luer connector having collars with female threads.
In one or more embodiments, the outer cap exterior wall surface includes a plurality of grip members.
In one or more embodiments, the female connector may be selected from the group consisting essentially of needle-free connectors, catheter luer connectors, stopcocks, and hemodialysis connectors.
In one or more embodiments, the male connector may be an intravenous tubing end, stopcock or male lock luer.
In one or more embodiments, the threads of the inner cap and the threads of the outer cap are void of interference to enable a sliding fit.
In one or more embodiments, the gaps of the one or more threads of the outer cap interior wall surface are disposed adjacent to the grooves of the outer cap interior wall surface to allow sliding of the inner cap against the outer cap.
The gaps of the one or more threads of the outer cap interior wall surface accommodate the one or more thread-tabs on the exterior wall surface of the second end of the inner cap when the inner cap slides against the outer cap.
In one or more embodiments, the two shaft-like wings on the exterior wall surface of the first end of the inner cap further comprise one or more pockets having a snap-fit arrangement with one or more protrusions disposed on the one or more grooves of the outer cap interior wall surface to fix the position of the inner cap with the outer cap.
When a male luer connector is engaged to the one or more threads of the exterior wall surface of the second end of the inner cap and rotated in a clockwise direction, the one or more pockets on the two shaft-like wings of the inner cap disengage from the one or more protrusions on the outer cap interior wall surface to allow the inner cap to partially protrude out from the opening end of the outer cap.
When a female luer connector is engaged to the device, the inner cap will be pushed and the one or more pockets on the two shaft-like wings of the inner cap disengage from the one or more protrusions on the outer cap interior wall surface to allow the inner cap to move toward the closed end of the chamber.
In one or more embodiments, the two shaft-like wings on the exterior wall surface of the first end of the inner cap further comprise one or more protrusions having a snap-fit arrangement with one or more corresponding one or more pockets disposed on the one or more grooves of the outer cap interior wall surface to fix the position of the inner cap with the outer cap.
When a male luer connector is engaged to the one or more threads of the exterior wall surface of the second end of the inner cap and rotated in a clockwise direction, the one or more pockets on the two shaft-like wings of the inner cap disengages from the one or more protrusions on the outer cap interior wall surface to allow the inner cap to partially protrude out from the opening end of the outer cap.
When a female luer connector is engaged to the device, the inner cap will be pushed and the one or more pockets on the two shaft-like wings of the inner cap disengage from the one or more protrusions on the outer cap interior wall surface to allow the inner cap to move toward the closed end of the chamber.
Inner cap can slide back and forth with respect to outer cap. In one or more embodiments, the open end of the outer cap is situated on a same horizontal plane as the second end of the inner cap in an initial state. When a male luer connector is engaged to the one or more threads of the exterior wall surface of the second end of the inner cap, the inner cap slides against the outer cap to partially protrude out from the open end of the outer cap. When a female luer connector is engaged to the device, the inner cap slides against the outer cap and retracts into the chamber of the outer cap to allow the female luer connector to engage the one or more threads on the interior wall surface of the outer cap. The threads of the inner cap and the threads of the outer cap are intrinsically non-interfering with each other, and are no longer restrained by interference that enables sliding fit.
Disinfecting caps currently on the market are capable of only disinfecting one of the three types of luer fitting, namely female luer of needle-free connectors, female luer of stopcocks, and male luer connectors on intravenous injection sites. Thus, to avoid having to use different types of disinfecting caps to clean different types of connectors, device is self-adaptive to different types of luer connectors due to the sliding mechanism between the inner cap that engages with male luer connectors and the outer cap that engages with female luer connectors thereby allowing the user to clean different types of connectors with a single device. Thus, to avoid having to use different types of disinfecting caps to clean different types of connectors, device and other embodiments of the present disclosure provides a single device to be used for cleaning different types of connectors. Upon mounting the outer cap onto female luer connectors, the inner cap retreats towards the chamber at the closed end of the outer cap, thus, providing space for female luer connectors to be inserted and screwed onto the threads of the outer cap. Upon mounting the inner cap of device onto a male luer connector, the one or more thread-tabs on the exterior wall surface of the second end of the inner cap engage with the threads on the male luer connector. Hence the disclosed cap can be mounted onto both male and female luers. The threads of the inner cap and the threads of the outer cap have little or no interference with each other, and the dimension of the threads of the inner cap and the threads of the outer cap are independent with each other while meeting the luer standard.
The device can achieve disinfection when used on luer connectors by integrating disinfectant or antimicrobial agent in the chamber of the outer cap. The disinfectant or antimicrobial agent can be directly included in the chamber or disinfectant or antimicrobial agent can be absorbed into sponges or foam material that fills the chamber of outer cap. In one or more embodiments, the disinfectant or antimicrobial agent is selected from the group consisting of isopropyl alcohol, ethanol, 2-propanol, butanol, methylparaben, ethylparaben, propylparaben, propyl gallate, butylated hydroxyanisole (BHA), butylated hydroxytoluene, t-butyl-hydroquinone, chloroxylenol, chlorohexidine, chlorhexidine diacetate, chlorohexidine gluconate, povidone iodine, alcohol, dichlorobenzyl alcohol, dehydroacetic acid, hexetidine, triclosan, hydrogen peroxide, colloidal silver, benzethonium chloride, benzalkonium chloride, octenidine, antibiotic, and mixtures thereof. In one or more embodiments, the disinfectant or antimicrobial agent may be a fluid or a gel. In one or more embodiments, the absorbent material compresses toward the closed end of the chamber upon connection to the female luer connector or the male luer connector. The compression of the absorbent material disinfects the female luer connector or the male luer connector.
The peelable seal on the end face to prevent the disinfectant or the antimicrobial agent from exiting the chamber.
In one or more embodiments, the outer cap exterior wall surface includes a plurality of grip members.
Another aspect of the present disclosure pertains to a device for connection to a medical connector according to a fourth exemplary embodiment of the present disclosure generally comprises an outer cap, an inner cap, and a peelable seal.
The outer cap comprises an integral body, a closed end, an annular wall having a length extending from the closed end to an open end and defining a chamber containing an absorbent material and disinfectant or antimicrobial agent. The open end of the outer cap defines an end face.
The annular wall of the outer cap comprises an outer cap exterior wall surface and an outer cap interior wall surface. The outer cap interior wall surface includes one or more pockets.
The inner cap comprises an integral body having an annular wall having an exterior wall surface and an interior wall surface with a first end of the inner cap facing the closed end of the outer cap, a second end of the inner cap facing the open end of the outer cap. The exterior wall surface of the first end of the inner cap includes a flexure hinge adapted to engage the one or more pockets of the interior wall surface of the outer cap to fix the position of the inner cap with the outer cap. The exterior wall surface of the second end of the inner cap includes one or more threads adapted to engage a male luer connector.
The peelable seal on the end face to prevent the disinfectant or the antimicrobial agent from exiting the chamber.
In one or more embodiments, the open end of the outer cap is situated on a same horizontal plane as the second end of the inner cap in an initial state.
In one or more embodiments, when a male luer connector is engaged to the one or more threads of the exterior wall surface of the second end of the inner cap and rotated in a clockwise direction, the flexure hinge on the inner cap disengages from the pocket on the outer cap interior wall surface to allow the inner cap to partially protrude out from the opening end of the outer cap.
In one or more embodiments, when a male luer connector is engaged to the one or more threads of the exterior wall surface of the second end of the inner cap and rotated in a counter-clockwise direction, the inner cap retracts into the chamber of the outer cap.
In one or more embodiments, when a female luer connector is engaged to the device, the inner cap will be pushed and the interlocking between the flexure hinge on the inner cap and the pocket on the outer cap will be dislodged to allow the inner cap to move toward the closed end of the chamber.
In one or more embodiments, the disinfectant or antimicrobial agent is selected from the group consisting of isopropyl alcohol, ethanol, 2-propanol, butanol, methylparaben, ethylparaben, propylparaben, propyl gallate, butylated hydroxyanisole (BHA), butylated hydroxytoluene, t-butyl-hydroquinone, chloroxylenol, chlorohexidine, chlorhexidine diacetate, chlorohexidine gluconate, povidone iodine, alcohol, dichlorobenzyl alcohol, dehydroacetic acid, hexetidine, triclosan, hydrogen peroxide, colloidal silver, benzethonium chloride, benzalkonium chloride, octenidine, antibiotic, and mixtures thereof.
In one or more embodiments, the outer cap exterior wall surface includes a plurality of grip members.
In one or more embodiments, the female luer connector is selected from the group consisting of needle-free connectors, stopcocks, and hemodialysis connectors.
In one or more embodiments, the male luer connector may be an intravenous tubing end, stopcock or male lock luer.
Another aspect of the present disclosure pertains to a device for connection to a medical connector according to a fifth exemplary embodiment of the present disclosure generally comprises an outer cap, an inner cap, and a peelable seal.
The outer cap comprises an integral body, a closed end, an annular wall having a length extending from the closed end to an open end and defining a chamber containing an absorbent material and disinfectant or antimicrobial agent. The open end of the annular wall defines an end face. In one or more embodiments, the annular wall comprises a flared curvature at the open end of the body defining an end face. The annular wall of the outer cap comprises an outer cap exterior wall surface and an outer cap interior wall surface, the interior wall surface having one or more protrusions. The inner cap comprises an integral body having an annular wall having an exterior wall surface and an interior wall surface with a first end of the inner cap facing the closed end of the outer cap, a second end of the inner cap facing the open end of the outer cap. The exterior wall surface of the first end of the inner cap includes a dimple adapted to engage the one or more protrusions of the interior wall surface of the outer cap to fix the position of the inner cap with the outer cap. The exterior wall surface of the second end of the inner cap includes one or more thread-tabs adapted to engage a male luer connector. The peelable seal on the end face to prevent the disinfectant or the antimicrobial agent from exiting the chamber.
In one or more embodiments, the outer cap exterior wall surface can include indicia, graphics, symbols, diagrams, words or other instructions.
In one or more embodiments, the open end of the outer cap may be situated on a same horizontal plane as the second end of the inner cap in an initial state.
When a male luer connector is engaged to the one or more threads of the exterior wall surface of the second end of the inner cap and rotated in a clockwise direction, the inner cap partially protrude out from the open end of the outer cap.
When a male luer connector is engaged to the one or more threads of the exterior wall surface of the second end of the inner cap and rotated in a counter-clockwise direction, the inner cap retracts into the chamber of the outer cap.
When a female luer connector is engaged to the device, the inner cap slips and retracts into the chamber of the outer cap.
In one or more embodiments, the disinfectant or antimicrobial agent is selected from the group consisting of isopropyl alcohol, ethanol, 2-propanol, butanol, methylparaben, ethylparaben, propylparaben, propyl gallate, butylated hydroxyanisole (BHA), butylated hydroxytoluene, t-butyl-hydroquinone, chloroxylenol, chlorohexidine, chlorhexidine diacetate, chlorohexidine gluconate, povidone iodine, alcohol, dichlorobenzyl alcohol, dehydroacetic acid, hexetidine, triclosan, hydrogen peroxide, colloidal silver, benzethonium chloride, benzalkonium chloride, octenidine, antibiotic, and mixtures thereof.
In one or more embodiments, the outer cap exterior wall surface includes a plurality of grip members.
In one or more embodiments, the female connector is selected from the group consisting of needle-free connectors, stopcocks, and hemodialysis connectors.
In one or more embodiments, the male connector may be an intravenous tubing end, stopcock or a male lock luer.
Before describing several exemplary embodiments of the disclosure, it is to be understood that the disclosure is not limited to the details of construction or process steps set forth in the following description. The disclosure is capable of other embodiments and of being practiced or being carried out in various ways.
Embodiments of the disclosure pertain to a universal single-use device for connection to and disinfection of a medical connector, including male luer connectors and female luer connectors, in which the device comprises an outer cap and inner luer. The device provides a mechanical barrier for connectors and contains an antimicrobial agent for disinfection. The device of the present disclosure allows the practitioner to streamline the disinfecting process.
With respect to terms used in this disclosure, the following definitions are provided.
As used herein, the use of “a,” “an,” and “the” includes the singular and plural.
As used herein, the term “catheter related bloodstream infection” or “CRBSI” refers to any infection resulting from the presence of a catheter or IV line.
As used herein, the term “Luer connector” refers to a connection collar that is the standard way of attaching syringes, catheters, hubbed needles, IV tubes, etc. to each other. The Luer connector consists of male and female interlocking tubes, slightly tapered to hold together better with even just a simple pressure/twist fit. Luer connectors can optionally include an additional outer rim of threading, allowing them to be more secure. The Luer connector male end is generally associated with a flush syringe and can interlock and connect to the female end located on the vascular access device (VAD). A Luer connector comprises a distal end, a proximal end, an irregularly shaped outer wall, a profiled center passageway for fluid communication from the chamber of the barrel of a syringe to the hub of a VAD. A Luer connector also has a distal end channel that releasably attaches the Luer connector to the hub of a VAD, and a proximal end channel that releasably attaches the Luer connector to the barrel of a syringe.
Referring to
When device 100 is removed from its packaging, the open end 110 of the outer cap 102 is situated on approximately a same horizontal plane P as the second end 144 of the inner cap 132 in an initial state. As used herein, the use of the phrase “approximately a same horizontal plane P” refers to a position in which the outer cap and the inner cap are close to each other but the inner cap does not protrude relative to the outer cap. To connect the device to a male luer connector, the user applies an axial load such that a male luer connector is engaged to the one or more threads 148 of the exterior wall surface 138 of the second end 144 of the inner cap 132 and rotated in a clockwise direction, the inner cap 132 partially protrudes out from the open end of the outer cap. When the inner cap 132 partially protrudes out from the open end 110 of the outer cap 102, there is no space that exists between the device and the connector. When a male luer connector is engaged to the one or more threads 148 of the exterior wall surface 138 of the second end 144 of the inner cap 132 and rotated in a counter-clockwise direction, the inner cap 132 retracts into the chamber 112 of the outer cap 102. In one or more embodiments, male luer connector can be detached from device 100 by counter-clockwise rotation without forcing inner cap 132 to retract. When a female luer connector is engaged to the device, the inner cap 132 slips and retracts into the chamber 112 of the outer cap 102. Once the device is engage to the connector, the device may be removed from the connector by rotating the device counter-clockwise. Upon disengagement, the inner cap 132 and the outer cap 102 remain intact and attached to each other.
Device 100 is designed to be compatible in interacting with various disinfectants. In one or more embodiments, the disinfectant or antimicrobial agent may include variations of alcohol or chlorhexidine. The disinfectant or antimicrobial agent can be a fluid or a gel selected from the group consisting essentially of isopropyl alcohol, ethanol, 2-propanol, butanol, methylparaben, ethylparaben, propylparaben, propyl gallate, butylated hydroxyanisole (BHA), butylated hydroxytoluene, t-butyl-hydroquinone, chloroxylenol, chlorohexidine, chlorhexidine diacetate, chlorohexidine gluconate, povidone iodine, alcohol, dichlorobenzyl alcohol, dehydroacetic acid, hexetidine, triclosan, hydrogen peroxide, colloidal silver, benzethonium chloride, benzalkonium chloride, octenidine, antibiotic, and mixtures thereof.
In one or more embodiments, the absorbent material compresses toward the closed end of the chamber upon connection to the female luer connector or the male luer connector. The compression of the absorbent material disinfects the female luer connector or the male luer connector.
The inner cap 132 and/or the outer cap 102 is made from any of a number of types of plastic materials such as polycarbonate, polypropylene, polyethylene, glycol-modified polyethylene terephthalate, acrylonitrile butadiene styrene or any other moldable plastic material used in medical devices.
In one or more embodiments, the outer cap exterior wall surface 118 includes a plurality of grip members 119.
In one or more embodiments, the female connector may be a needle-free connector, stopcock, or hemodialysis connector. In one or more embodiments, the needleless connector is selected from a Q-SYTLE connector, MAXPLUS, MAXPLUS CLEAR, MAXZERO, ULTRASITE, CARESITE, INVISION-PLUS, SAFELINE, ONELINK, V-LINK, CLEARLINK, NEUTRACLEAR, CLAVE, MICROCLAVE, MICROCLAVE CLEAR, NEUTRON, NANOCLAVE, KENDALL, NEXUS, INVISION, VADSITE, BIONECTOR, etc. In one or more embodiments, the male connector may be an intravenous tubing end or stopcock.
Referring to
As shown in
The inner cap 232 comprises a body 234 having an annular wall 236 having an exterior wall surface 238 and an interior wall surface 240 with a first end 242 of the inner cap facing the closed end 206 of the outer cap 202. A second end 244 of the inner cap 232 faces the open end 210 of the outer cap 202. The outer cap interior wall surface 220 comprises one or more grooves 224 along which the inner cap 232 is able to slide. The exterior wall surface 238 of the first end 242 of the inner cap 232 includes two shaft-like wings 247 to fit into the one or more grooves 224 of the outer cap interior wall surface 220 and facilitate the slide motion without allowing signification relative rotation between the inner cap 232 with respect to the outer cap 202. The outer-most diameter of the threads of the inner cap is designed to have minimum interference, e.g. sliding fit or strip fit, with the threads of the outer cap to allow relative linear motion and also facilitate assembly of device 200. The teeth depth of the threads of the inner cap and the outer cap is desired to be sufficient to engage with the male and female luer connectors. The exterior wall surface 238 of the second end 244 of the inner cap 232 includes one or more thread-tabs 248 adapted to engage a male luer connector. In one or more embodiments, the exterior wall surface 238 of the second end 244 of the inner cap 232 includes two thread-tabs 248 adapted to engage a male luer connector. The male luer connectors include collars with female threads. In one or more embodiments, the male connector can be an intravenous (I.V.) tubing end, stopcock or male lock luer.
Inner cap 232 can slide back and forth with respect to outer cap 202. In one or more embodiments, the open end 210 of the outer cap 202 is situated on a same horizontal plane P as the second end 244 of the inner cap 232 in an initial state. When a male luer connector is engaged to the one or more thread-tabs 248 of the exterior wall surface 238 of the second end 244 of the inner cap 232, the inner cap 232 slides against the outer cap 202 to partially protrude out from the open end 210 of the outer cap 202. When a female luer connector is engaged to device 200, the inner cap 232 slides against the outer cap 202 and retracts into the chamber 212 of the outer cap 202 to allow the female luer connector to engage the one or more threads 222 on the interior wall surface 220 of the outer cap 202.
The inner cap 232 and/or the outer cap 202 is made from any of a number of types of plastic materials such as polycarbonate, polypropylene, polyethylene, glycol-modified polyethylene terephthalate, acrylonitrile butadiene styrene or any other moldable plastic material used in medical devices.
Disinfecting caps currently on the market are capable of only disinfecting one of the three types of luer fitting, namely female luer of needle-free connectors, female luer of stopcocks, and male luer connectors on intravenous injection sites. Thus, to avoid having to use different types of disinfecting caps to clean different types of connectors, device 200 is self-adaptive to different types of luer connectors due to the sliding mechanism between the inner cap that engages with male luer connectors and the outer cap that engages with female luer connectors thereby allowing the user to clean different types of connectors with a single device. As discussed above, upon mounting the outer cap 202 onto female luer connectors, the inner cap 232 retreats towards the chamber 212 at the closed end 206 of the outer cap 202, thus, providing space for female luer connectors to be inserted and screwed onto the threads 222 of the outer cap 202. Upon mounting the inner cap 232 of device 200 onto a male luer connector, the one or more thread-tabs 248 on the exterior wall surface 238 of the second end 244 of the inner cap 232 engage with the threads on the male luer connector. Hence the disclosed cap can be mounted onto both male and female luers.
The device 200 can achieve disinfection when used on luer connectors by integrating disinfectant or antimicrobial agent in the chamber of the outer cap. The disinfectant or antimicrobial agent can be directly included in the chamber or disinfectant or antimicrobial agent can be absorbed into sponges or foam material that fills the chamber of outer cap. In one or more embodiments, the disinfectant or antimicrobial agent is selected from the group consisting essentially of isopropyl alcohol, ethanol, 2-propanol, butanol, methylparaben, ethylparaben, propylparaben, propyl gallate, butylated hydroxyanisole (BHA), butylated hydroxytoluene, t-butyl-hydroquinone, chloroxylenol, chlorohexidine, chlorhexidine diacetate, chlorohexidine gluconate, povidone iodine, alcohol, dichlorobenzyl alcohol, dehydroacetic acid, hexetidine, triclosan, hydrogen peroxide, colloidal silver, benzethonium chloride, benzalkonium chloride, octenidine, antibiotic, and mixtures thereof.
The peelable seal on the end face 216 to prevent the disinfectant or the antimicrobial agent from exiting the chamber 212.
In one or more embodiments, the outer cap exterior wall surface 218 includes a plurality of grip members.
The outer-most diameter of the one or more thread-tabs of the inner cap has a minimum interference with the threads of the outer cap to allow for relative linear motion.
Referring to
The outer cap 302 comprises an integral body 304, a closed end 306, an annular wall 308 having a length LO3 extending from the closed end 306 to an open end 310 and defining a chamber 312 containing an absorbent material and disinfectant or antimicrobial agent. The open end defines an end face 316.
The annular wall of the outer cap comprises an outer cap exterior wall surface 318 and an outer cap interior wall surface 320. The outer cap interior wall surface includes one or more grooves 324 and one or more threads 322 adapted to engage with a female luer connector, wherein at least a portion of said one or more threads 322 on the outer cap interior wall surface 320 comprise one or more gaps 326 that does not engage a mating feature of the inner cap 332.
The inner cap 332 slidably engages with the outer cap 302. The inner cap 332 comprises an integral body 334 having an annular wall 336 having an exterior wall surface 338 and an interior wall surface 340 with a first end 342 of the inner cap 332 facing the closed end 306 of the outer cap 302 and a second end 344 of the inner cap 332 facing the open end 310 of the outer cap 302. The exterior wall surface 338 of the first end 342 of the inner cap 332 includes two shaft-like wings 347 to fit into the one or more grooves 324 of the outer cap interior wall surface 320 and facilitate the slide motion without allowing significant relative rotation between the inner cap 332 with respect to the outer cap 302. The exterior wall surface 338 of the second end 344 of the inner cap 332 includes one or more thread-tabs 348 adapted to engage a male luer connector. The inner cap 332 is in a slidable arrangement with the outer cap 302.
The function of the one or more gaps 326 is to accommodate the one or more thread-tabs 348 adapted to engage a male luer connector on the inner cap 332 when sliding motion occurs. The position of the one or more gaps 326, as well as the position of the threads on the inner cap, is to be adjacent to the sliding grooves 324 in order to minimize the gap size and utilize the width of the sliding groove 324 as a part of an accommodation space. The thread-tabs 348 of the inner cap 332 and the threads 322 of the outer cap 302 are no longer restrained by interference therefore enabling a sliding fit. The dimension of threads can be optimized to maximize the engagement between the thread-tabs 348 of the inner cap 332 and the outer cap 302 to the correspondent connectors which improves the mechanical performance of the device when used with connectors in terms of resistance to overriding torque and resistance to axial separation force, hence allowing the device to be more securely attached to luer connectors.
The inner cap 332 and/or the outer cap 302 is made from any of a number of types of plastic materials such as polycarbonate, polypropylene, polyethylene, glycol-modified polyethylene terephthalate, acrylonitrile butadiene styrene or any other moldable plastic material used in medical devices.
The peelable seal on the end face is to prevent the disinfectant or the antimicrobial agent from exiting the chamber.
In one or more embodiments, the open end 310 of the outer cap 302 is situated on a same horizontal plane as the second end 344 of the inner cap 332 in an initial state.
When a male luer connector is engaged to the one or more threads of the exterior wall surface of the second end of the inner cap and rotated in a clockwise direction, the inner cap 332 partially protrude out from the open end 310 of the outer cap 302.
When a male luer connector is engaged to the one or more thread-tabs 348 of the exterior wall surface 338 of the second end 344 of the inner cap 332 and rotated in a counter-clockwise direction, the inner cap 332 retracts into the chamber 312 of the outer cap 302.
When a female luer connector is engaged to the device 300, the inner cap 332 slides against the outer cap 302 and retracts into the chamber 312 of the outer cap 302 to allow the female luer connector to engage the one or more threads 322 on the interior wall surface 320 of the outer cap 302.
In one or more embodiments, the exterior wall surface 338 of the second end 344 of the inner cap 332 includes two thread-tabs 348 adapted to engage a male luer connector having collars with female threads
In one or more embodiments, the outer cap exterior wall surface 318 includes a plurality of grip members.
In one or more embodiments, the female connector may be selected from the group consisting of needle-free connectors, catheter luer connectors, stopcocks, and hemodialysis connectors.
In one or more embodiments, the male connector may be an intravenous tubing, stopcock end or male lock luer.
In one or more embodiments, the threads of the inner cap and the threads of the outer cap are void of interference to enable a sliding fit.
In one or more embodiments, the gaps 326 of the one or more threads 322 of the outer cap interior wall surface 320 are disposed adjacent to the grooves 324 of the outer cap interior wall surface 320 to allow sliding of the inner cap 332 against the outer cap 302.
The gaps 326 of the one or more threads 322 of the outer cap interior wall surface 320 accommodate the one or more thread-tabs 348 on the exterior wall surface 338 of the second end 344 of the inner cap 332 when the inner cap 332 slides against the outer cap 302.
In one or more embodiments, a snapping mechanism may be introduced at the rear end of inner cap 332 to lock in position with the outer cap 302 so that it can stay in place upon assembly. The mechanism has an interference such that the force resulting from screwing inner cap on male connectors can dislocate the inner cap, as well as the force resulting from pushing on the inner cap by female connector can dislocate the inner cap.
In one or more specific embodiments, the two shaft-like wings 347 on the exterior wall surface 338 of the first end 342 of the inner cap further comprise one or more pockets 349 having a snap-fit arrangement with one or more protrusions 380 disposed on the one or more grooves 324 of the outer cap interior wall surface 320 to fix the position of the inner cap 332 with the outer cap 302.
When a male luer connector is engaged to the one or more thread-tabs 348 of the exterior wall surface 338 of the second end 344 of the inner cap 332 and rotated in a clockwise direction, the one or more pockets 349 on the two shaft-like wings 347 of the inner cap 332 disengage from the one or more protrusions 380 on the outer cap interior wall surface 320 to allow the inner cap 332 to partially protrude out from the open end 310 of the outer cap 302.
When a female luer connector is engaged to the device, the inner cap 332 will be pushed and the one or more pockets 349 on the two shaft-like wings 347 of the inner cap 332 disengage from the one or more protrusions 380 on the outer cap interior wall surface 320 to allow the inner cap 332 to move toward the closed end 306 of the outer cap and into the chamber 312.
In one or more embodiments, the two shaft-like wings 347 on the exterior wall surface 338 of the first end 342 of the inner cap 332 further comprise one or more protrusions 380 having a snap-fit arrangement with one or more corresponding one or more pockets 349 disposed on the one or more grooves 324 of the outer cap interior wall surface 320 to fix the position of the inner cap 332 with the outer cap 302.
Inner cap 332 can slide back and forth with respect to outer cap 302. In one or more embodiments, the open end 310 of the outer cap 302 is situated on the same horizontal plane P as the second end 344 of the inner cap 332 in an initial state. When a male luer connector is engaged to the one or more thread-tabs 348 of the exterior wall surface 338 of the second end 344 of the inner cap 332, the inner cap 332 slides against the outer cap 302 to partially protrude out from the open end 310 of the outer cap 302. When a female luer connector is engaged to the device 300, the inner cap 332 slides against the outer cap 302 and retracts into the chamber 312 of the outer cap 302 to allow the female luer connector to engage the one or more threads 322 on the interior wall surface 320 of the outer cap 302. The thread-tabs 348 of the inner cap 332 and the threads 322 of the outer cap 302 are intrinsically non-interfering with each other, and are no longer restrained by interference that enables sliding fit.
Disinfecting caps currently on the market are capable of only disinfecting one of the three types of luer fitting, namely female luer of needle-free connectors, female luer of stopcocks, and male luer connectors on intravenous injection sites. Thus, to avoid having to use different types of disinfecting caps to clean different types of connectors, device 300 is self-adaptive to different types of luer connectors due to the sliding mechanism between the inner cap 332 that engages with male luer connectors and the outer cap 302 that engages with female luer connectors thereby allowing the user to clean different types of connectors with a single device. Thus, to avoid having to use different types of disinfecting caps to clean different types of connectors, device 300 and other embodiments of the present disclosure provides a single device to be used for cleaning different types of connectors. Upon mounting the outer cap 302 onto female luer connectors, the inner cap 332 retreats towards the chamber 312 at the closed end 306 of the outer cap 302, thus, providing space for female luer connectors to be inserted and screwed onto the threads 322 of the outer cap. Upon mounting the inner cap of device 300 onto a male luer connector, the one or more thread-tabs 348 on the exterior wall surface 338 of the second end 344 of the inner cap 332 engage with the threads on the male luer connector. Hence the disclosed cap can be mounted onto both male and female luers. The threads of the inner cap and the threads of the outer cap are intrinsically non-interfering with each other and the dimension of the threads of the inner cap and the threads of the outer cap are independent with each other while meeting the luer standard.
The device 300 can achieve disinfection when used on luer connectors by integrating an absorbent material having a disinfectant or antimicrobial agent in the chamber 312 of the outer cap 302. The disinfectant or antimicrobial agent can be directly included in the chamber or disinfectant or antimicrobial agent can be absorbed into sponges or foam material that fills the chamber of outer cap. In one or more embodiments, the disinfectant or antimicrobial agent is selected from the group consisting of isopropyl alcohol, ethanol, 2-propanol, butanol, methylparaben, ethylparaben, propylparaben, propyl gallate, butylated hydroxyanisole (BHA), butylated hydroxytoluene, t-butyl-hydroquinone, chloroxylenol, chlorohexidine, chlorhexidine diacetate, chlorohexidine gluconate, povidone iodine, alcohol, dichlorobenzyl alcohol, dehydroacetic acid, hexetidine, triclosan, hydrogen peroxide, colloidal silver, benzethonium chloride, benzalkonium chloride, octenidine, antibiotic, and mixtures thereof. In one or more embodiments, the disinfectant or antimicrobial agent may be a fluid or a gel. In one or more embodiments, the absorbent material compresses toward the closed end of the chamber upon connection to the female luer connector or the male luer connector. The compression of the absorbent material disinfects the female luer connector or the male luer connector.
The peelable seal on the end face 316 to prevent the disinfectant or the antimicrobial agent from exiting the chamber 312.
In one or more embodiments, the outer cap exterior wall surface 318 includes a plurality of grip members.
Referring to
The outer cap 402 comprises an integral body 404, a closed end 406, an outer cap annular wall 408 having a length Loo extending from the closed end 406 to an open end 410 and defining a chamber 412 containing an absorbent material and disinfectant or antimicrobial agent. The open end 410 of the outer cap 402 defines an end face 416.
The outer cap annular wall 408 comprises an outer cap exterior wall surface 418 and an outer cap interior wall surface 420. The outer cap interior wall surface 420 includes one or more pockets 460.
The inner cap 432 comprises an integral body 404 having an annular wall 436 having an exterior wall surface 438 and an interior wall surface 440 with a first end 442 of the inner cap facing the closed end of the outer cap, a second end 444 of the inner cap facing the open end of the outer cap. The exterior wall surface of the first end of the inner cap includes a flexure hinge 470 adapted to engage the one or more pockets 460 of the outer cap interior wall surface 420 to fix the position of the inner cap 432 with the outer cap 402. The exterior wall surface 438 of the second end 444 of the inner cap 432 includes one or more thread-tabs 448 adapted to engage a male luer connector.
In one or more embodiments, the inner cap 432 is connected to the interior surface 420 of the outer cap by an elastic element designed as a flexure hinge 470, as shown in
In one or more embodiments, flexure hinge 470 may be made from a plastic material preferably such as injection molded polypropylene or ultra-high molecular weight polyethylene (UHMW-PE) whose material properties permit a short flexure length while at the same time permitting a high number of flexing motion cycles.
The peelable seal on the end face 416 to prevent the disinfectant or the antimicrobial agent from exiting the chamber 412.
In one or more embodiments, the open end 410 of the outer cap 402 is situated on a same horizontal plane as the second end 444 of the inner cap 432 in an initial state.
When a male luer connector is engaged to the one or more thread-tabs 448 of the exterior wall surface 438 of the second end 444 of the inner cap 432 and the connector is rotated in a clockwise direction when viewed from the open end of the cap, the flexure hinge 470 on the inner cap disengages from the pocket 449 on the outer cap interior wall surface 420 to allow the inner cap 432 to partially protrude out from the open end 410 of the outer cap 402. When a male luer connector is engaged to the one or more thread-tabs 448 of the exterior wall surface 438 of the second end 444 of the inner cap 432 and rotated in a counter-clockwise direction, the inner cap 432 retracts into the chamber 412 of the outer cap 402.
When a female luer connector is engaged to the device, the inner cap 432 will be pushed and the interlocking between the flexure hinge 470 on the inner cap and the pocket 449 on the outer cap will be dislodged to allow the inner cap 432 to move toward the closed end 406 of the outer cap and into the chamber 412.
The inner cap 432 and/or the outer cap 402 is made from any of a number of types of plastic materials such as polycarbonate, polypropylene, polyethylene, glycol-modified polyethylene terephthalate, acrylonitrile butadiene styrene or any other moldable plastic material used in medical devices.
In one or more embodiments, the disinfectant or antimicrobial agent is selected from the group consisting of isopropyl alcohol, ethanol, 2-propanol, butanol, methylparaben, ethylparaben, propylparaben, propyl gallate, butylated hydroxyanisole (BHA), butylated hydroxytoluene, t-butyl-hydroquinone, chloroxylenol, chlorohexidine, chlorhexidine diacetate, chlorohexidine gluconate, povidone iodine, alcohol, dichlorobenzyl alcohol, dehydroacetic acid, hexetidine, triclosan, hydrogen peroxide, colloidal silver, benzethonium chloride, benzalkonium chloride, octenidine, antibiotic, and mixtures thereof.
In one or more embodiments, the outer cap exterior wall surface 418 includes a plurality of grip members 419.
In one or more embodiments, the female luer connector may be selected from a group consisting of needle-free connectors, stopcocks, and hemodialysis connectors.
In one or more embodiments, the male luer connector may be an intravenous tubing end, stopcock or male lock luer.
Referring to
The outer cap 502 comprises an integral body 504, a closed end 506, an annular wall 508 having a length LO5 extending from the closed end 506 to an open end 510 and defining a chamber 512 containing an absorbent material 514 and disinfectant or antimicrobial agent. The open end of the body defines an end face 516. In one or more embodiments, the annular wall comprises a flared curvature at the open end of the body defining an end face 516. In one or more embodiments, the integral body 504 of the outer cap has a geometry that is modified to reduce the outer diameter and height of the outer cap. The reduction in size and weight reduces the risk of interfering with patients' activity and irritation on patients' skin. Luer threads on the inner cap are designed to not interfere with the threads on the outer cap without additional cuts into the outer cap threads, thus facilitate the molding process.
The outer cap annular wall 508 comprises an outer cap exterior wall surface 538 and an outer cap interior wall surface 540, the interior wall surface 540 having one or more protrusions 580. The inner cap 532 comprises an integral body 534 having an annular wall 536 having an exterior wall surface 538 and an interior wall surface 540 with a first end 542 of the inner cap facing the closed end of the outer cap, a second end 544 of the inner cap facing the open end of the outer cap. The exterior wall surface of the first end of the inner cap includes a dimple 590 adapted to engage the one or more protrusions of the interior wall surface of the outer cap to fix the position of the inner cap with the outer cap. The exterior wall surface of the second end of the inner cap includes one or more thread-tabs 548 adapted to engage a male luer connector. The peelable seal 550 on the end face 516 to prevent the disinfectant or the antimicrobial agent from exiting the chamber 512.
In one or more embodiments, the open end of the outer cap may be situated on a same horizontal plane as the second end of the inner cap in an initial state.
When a male luer connector is engaged to the one or more thread-tabs 548 of the exterior wall surface 538 of the second end 544 of the inner cap 532 and rotated in a clockwise direction, the inner cap 532 partially protrude out from the open end 510 of the outer cap 502.
When a male luer connector is engaged to the one or more thread-tabs 548 of the exterior wall surface of the second end of the inner cap and rotated in a counter-clockwise direction, the inner cap 532 retracts into the chamber 512 of the outer cap 502.
When a female luer connector is engaged to the device, the inner cap 532 slips and retracts into the chamber 512 of the outer cap 502.
In one or more embodiments, the disinfectant or antimicrobial agent is selected from the group consisting of isopropyl alcohol, ethanol, 2-propanol, butanol, methylparaben, ethylparaben, propylparaben, propyl gallate, butylated hydroxyanisole (BHA), butylated hydroxytoluene, t-butyl-hydroquinone, chloroxylenol, chlorohexidine, chlorhexidine diacetate, chlorohexidine gluconate, povidone iodine, alcohol, dichlorobenzyl alcohol, dehydroacetic acid, hexetidine, triclosan, hydrogen peroxide, colloidal silver, benzethonium chloride, benzalkonium chloride, octenidine, antibiotic, and mixtures thereof.
In one or more embodiments, the outer cap exterior wall surface 518 can include indicia, graphics, symbols, diagrams, words or other instructions.
In one or more embodiments, curvature is added to the outer cap exterior wall surface 518. In one or more embodiments, a plurality of gripping members 519 is added to the outer cap exterior wall surface 518 to enhance the grip. In one or more embodiments, the plurality of gripping members 519 may be in the form of ribs.
The inner cap 532 and/or the outer cap 502 is made from any of a number of types of plastic materials such as polycarbonate, polypropylene, polyethylene, glycol-modified polyethylene terephthalate, acrylonitrile butadiene styrene or any other moldable plastic material used in medical devices.
As shown in
As shown in
Referring to
In one or more embodiments, the cap of the device of the present disclosure has threads that have a size and pitch to engage a threadable segment of a female connector, such as for example, a female luer connector. Such connectors are generally and commonly used as catheter and other fluid-tight protective connectors in medical applications. In some embodiments, the cap provides a protective cover for a female luer connector when engaged with the connector when threads from the female luer connector engage and form a releasable connection with threads of the cap.
In some embodiments, the connector comprises a needleless injection site, which may sometimes be referred to as a needleless injection port, hub, valve, or device, or as a needleless access site, port, hub, valve, or device, and which can include such brands as, for example, Clave® (available from ICU Medical, Inc.), SmartSite® (available from Cardinal Health, Inc.), and Q-Syte™ (available from Becton, Dickinson and Company). In some embodiments, the cap can be connected with any of a variety of different needleless injection sites, such as those previously listed. In one or more embodiments, after the cap has been coupled with connector, it is unnecessary to disinfect (e.g. treat with an alcohol swab) the connector prior to each reconnection of the connector with another connector, as the connector will be kept in an uncontaminated state while coupled with the cap. Use of the cap replaces the standard swabbing protocol for cleaning connectors.
In one or more embodiments, threads of the cap are sized and pitched to engage threads of a male luer-lock connector. For example, connector can comprise the end of an IV tubing set that is disconnected from an IV catheter needleless injection site.
Reference throughout this specification to “one embodiment,” “certain embodiments,” “one or more embodiments” or “an embodiment” means that a particular feature, structure, material, or characteristic described in connection with the embodiment is included in at least one embodiment of the disclosure. Thus, the appearances of the phrases such as “in one or more embodiments,” “in certain embodiments,” “in one embodiment” or “in an embodiment” in various places throughout this specification are not necessarily referring to the same embodiment of the disclosure. Furthermore, the particular features, structures, materials, or characteristics may be combined in any suitable manner in one or more embodiments.
Although the disclosure herein has provided a description with reference to particular embodiments, it is to be understood that these embodiments are merely illustrative of the principles and applications of the present disclosure. It will be apparent to those skilled in the art that various modifications and variations can be made to the method and apparatus of the present disclosure without departing from the spirit and scope of the disclosure. Thus, it is intended that the present disclosure include modifications and variations that are within the scope of the appended claims and their equivalents.
This application is a divisional of U.S. patent application Ser. No. 16/378,015, filed on Apr. 8, 2019, which claims priority under 35 U.S.C. § 119(e) to U.S. Provisional Application No. 62/655,489, filed Apr. 10, 2018, the disclosures of which are incorporated herein by reference in their entirety.
| Number | Name | Date | Kind |
|---|---|---|---|
| 3403679 | Sinclair et al. | Oct 1968 | A |
| 4417890 | Dennehey et al. | Nov 1983 | A |
| 4597758 | Aalto et al. | Jul 1986 | A |
| 4642102 | Ohmori | Feb 1987 | A |
| 4711363 | Marino | Dec 1987 | A |
| 4738376 | Markus | Apr 1988 | A |
| 4906231 | Young | Mar 1990 | A |
| 5084017 | Maffetone | Jan 1992 | A |
| 5496288 | Sweeny | Mar 1996 | A |
| 5676406 | Simmons et al. | Oct 1997 | A |
| 5755696 | Caizza | May 1998 | A |
| 6632199 | Tucker et al. | Oct 2003 | B1 |
| 7083605 | Miyahara | Aug 2006 | B2 |
| 8012131 | Moser et al. | Sep 2011 | B2 |
| 8388894 | Colantonio | Mar 2013 | B2 |
| 8647308 | Solomon et al. | Feb 2014 | B2 |
| 8715231 | Woehr | May 2014 | B2 |
| 8721627 | Alpert et al. | May 2014 | B2 |
| 8777504 | Shaw et al. | Jul 2014 | B2 |
| 8784388 | Charles et al. | Jul 2014 | B2 |
| 8961475 | Solomon et al. | Feb 2015 | B2 |
| 9039989 | Lui et al. | Mar 2015 | B2 |
| 9132223 | Wakeel | Sep 2015 | B1 |
| 9192449 | Kerr et al. | Nov 2015 | B2 |
| 10099048 | Chiu et al. | Oct 2018 | B2 |
| 10166381 | Gardner et al. | Jan 2019 | B2 |
| 10376686 | Burkholz et al. | Aug 2019 | B2 |
| 10589080 | Hitchcock et al. | Mar 2020 | B2 |
| 10603481 | Avula et al. | Mar 2020 | B2 |
| 10871246 | Marici et al. | Dec 2020 | B2 |
| 11353147 | Marici | Jun 2022 | B2 |
| 11511100 | Ryan | Nov 2022 | B2 |
| 11628288 | Solomon et al. | Apr 2023 | B1 |
| 20030209681 | Leinsing et al. | Nov 2003 | A1 |
| 20040039341 | Ranalletta | Feb 2004 | A1 |
| 20040044318 | Fiser et al. | Mar 2004 | A1 |
| 20050147525 | Bousquet | Jul 2005 | A1 |
| 20050197646 | Connell et al. | Sep 2005 | A1 |
| 20070060904 | Vedrine et al. | Mar 2007 | A1 |
| 20080010766 | Kaufman et al. | Jan 2008 | A1 |
| 20080171995 | Vitullo et al. | Jul 2008 | A1 |
| 20080177250 | Howlett et al. | Jul 2008 | A1 |
| 20100000040 | Shaw et al. | Jan 2010 | A1 |
| 20100049170 | Solomon et al. | Feb 2010 | A1 |
| 20100050351 | Colantonio et al. | Mar 2010 | A1 |
| 20100100056 | Cawthon et al. | Apr 2010 | A1 |
| 20110046603 | Felsovalyi et al. | Feb 2011 | A1 |
| 20110054440 | Lewis | Mar 2011 | A1 |
| 20110213341 | Solomon et al. | Sep 2011 | A1 |
| 20110264037 | Foshee et al. | Oct 2011 | A1 |
| 20120039764 | Solomon et al. | Feb 2012 | A1 |
| 20120111368 | Rahimy | May 2012 | A1 |
| 20120123386 | Tsals | May 2012 | A1 |
| 20120302997 | Gardner et al. | Nov 2012 | A1 |
| 20130085474 | Charles et al. | Apr 2013 | A1 |
| 20130171030 | Ferlic et al. | Jul 2013 | A1 |
| 20130197485 | Gardner | Aug 2013 | A1 |
| 20130338644 | Solomon et al. | Dec 2013 | A1 |
| 20140052074 | Tekeste | Feb 2014 | A1 |
| 20140150832 | Rogers et al. | Jun 2014 | A1 |
| 20150094666 | Bates et al. | Apr 2015 | A1 |
| 20150374968 | Solomon et al. | Dec 2015 | A1 |
| 20160045629 | Gardner et al. | Feb 2016 | A1 |
| 20160067422 | Davis et al. | Mar 2016 | A1 |
| 20160158520 | Ma | Jun 2016 | A1 |
| 20170203092 | Ryan et al. | Jul 2017 | A1 |
| 20180085568 | Drmanovic | Mar 2018 | A1 |
| 20180200145 | Sanders et al. | Jul 2018 | A1 |
| 20180200500 | Ziebol et al. | Jul 2018 | A1 |
| 20180237190 | Iwasaki | Aug 2018 | A1 |
| 20180243547 | Fox et al. | Aug 2018 | A1 |
| 20180256879 | Chiu et al. | Sep 2018 | A1 |
| 20180256883 | Follman et al. | Sep 2018 | A1 |
| 20190151643 | Alpert | May 2019 | A1 |
| 20190234540 | Marici et al. | Aug 2019 | A1 |
| 20190308006 | Erekovcanski et al. | Oct 2019 | A1 |
| 20190351212 | Dudar et al. | Nov 2019 | A1 |
| 20210100996 | Wijesuriya et al. | Apr 2021 | A1 |
| 20210187267 | Jiang | Jun 2021 | A1 |
| 20220273931 | Jiang et al. | Sep 2022 | A1 |
| 20230080687 | Ryan | Mar 2023 | A1 |
| Number | Date | Country |
|---|---|---|
| 2523133 | Feb 2013 | CA |
| 101980746 | Feb 2011 | CN |
| 201807018 | Apr 2011 | CN |
| 102188766 | Sep 2011 | CN |
| 102448502 | May 2012 | CN |
| 103083767 | May 2013 | CN |
| 204161736 | Feb 2015 | CN |
| 206198472 | May 2017 | CN |
| 20017013 | Dec 2000 | DE |
| 10247963 | May 2004 | DE |
| 2606930 | Jun 2013 | EP |
| 2832391 | Jan 2018 | EP |
| 3275490 | Jan 2018 | EP |
| 2408259 | May 2005 | GB |
| 2518646 | Apr 2015 | GB |
| 103139363 | Jun 1991 | JP |
| H04501672 | Mar 1992 | JP |
| 2001502191 | Feb 2001 | JP |
| 2001521792 | Nov 2001 | JP |
| 2004208740 | Jul 2004 | JP |
| 2008239164 | Oct 2008 | JP |
| 2010527276 | Aug 2010 | JP |
| 2012522593 | Sep 2012 | JP |
| 2015517377 | Jun 2015 | JP |
| 2016511119 | Apr 2016 | JP |
| 2016104214 | Jun 2016 | JP |
| 200024442 | May 2000 | WO |
| 200224551 | Mar 2002 | WO |
| 2011066586 | Jun 2011 | WO |
| 2013046857 | Apr 2013 | WO |
| 2014159346 | Oct 2014 | WO |
| 2015127285 | Aug 2015 | WO |
| 2015174953 | Nov 2015 | WO |
| 2016158144 | Oct 2016 | WO |
| 2017087400 | May 2017 | WO |
| 2017095373 | Jun 2017 | WO |
| 2018106508 | Jun 2018 | WO |
| 2018237090 | Dec 2018 | WO |
| 2019147906 | Aug 2019 | WO |
| 2019152482 | Aug 2019 | WO |
| 2019212637 | Nov 2019 | WO |
| 2020112767 | Jun 2020 | WO |
| Entry |
|---|
| “Final Office Action in U.S. Appl. No. 16/253,683, mailed on Dec. 23, 2020, 9 pages”. |
| “Final Office Action in U.S. Appl. No. 16/254,747, mailed on Jan. 22, 2021, 15 pages”. |
| “International Search Report and Written Opinion in PCT/US2019/015789, mailed Apr. 16, 2019, 12 pages”. |
| “Non-Final Office Action in U.S. Appl. No. 15/838,461 dated Jul. 24, 2020, 10 pages”. |
| “Non-Final Office Action in U.S. Appl. No. 16/253,683, mailed on Jun. 26, 2020, 9 pages”. |
| “Non-Final Office Action in U.S. Appl. No. 16/254,747, mailed on Aug. 20, 2020, 14 pages”. |
| “PCT International Search Report and Written Opinion in PCT/US2019/026482 dated Jul. 30, 2019, 13 pages”. |
| “PCT International Search Report and Written Opinion in PCT/US2020/015535 dated May 4, 2020, 13 pages”. |
| “PCT International Search Report and Written Opinion in PCT/US2020/041097 dated Oct. 28, 2020, 18 pages”. |
| “PCT International Search Report and Written Opinion in PCT/US2020/041312 dated Oct. 19, 2020, 11 pages”. |
| “PCT International Search Report and Written Opinion in PCT/US2020/044942 dated Oct. 16, 2020, 15 pages”. |
| “PCT International Search Report and Written Opinion in PCT/US2020/044951 dated Oct. 14, 2020, 14 pages”. |
| “PCT International Search Report and Written Opinion in PCT/US2020/057611 dated Feb. 5, 2021, 11 pages”. |
| “PCT International Search Report and Written Opinion in PCT/US2020/065229 dated Mar. 29, 2021, 11 pages”. |
| “PCT International Search Report and Written Opinion in PCT/US2021/027214 dated Jul. 19, 2021, 14 pages”. |
| “PCT International Search Report and Written Opinion in PCT/US2021/027218 dated Jul. 22, 2021, 14 pages”. |
| “PCT International Search Report and Written Opinion in PCT/US2021/027219 dated Oct. 22, 2021, 22 pages”. |
| “PCT International Search Report and Written Opinion in PCT/US2021/027220 dated Jul. 21, 2021, 15 pages”. |
| “PCT Invitation to Pay Additional Fees in PCT/US2021/019546, mailed on Jun. 15, 2021, 17 pages”. |
| “PCT Invitation to Pay Additional Fees in PCT/US2021/027219, mailed on Jul. 22, 2021, 15 pages”. |
| Number | Date | Country | |
|---|---|---|---|
| 20220152374 A1 | May 2022 | US |
| Number | Date | Country | |
|---|---|---|---|
| 62655489 | Apr 2018 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 16378015 | Apr 2019 | US |
| Child | 17592810 | US |
